Summary
- Current Price
- As of today, CNSP price is $3.11, up +1.30% on
- Current Price All-Time High
- CNSP price is currently -100.00% below its historical high of $5,121,000.00 set on
- Market Cap
- CNSP current market cap is $2M, down -50.73% year-over-year
- PE Ratio
- CNSP PE ratio is unknown
- Revenue
- CNSP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for CNSP has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | CNS Pharmaceuticals, Inc. |
| Ticker | NASDAQ: CNSP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cnspharma.com |
| Employees | 4 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $3.11 | ||
| Price, 1D Change | +1.30% | |
| $2M | ||
| - | ||
| - | ||
| 1.04 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$466.44 | ||
| EPS, 1Y Change | -86.43% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$466.44 | ||
| EPS Estimate | N/A | -$27.43 |
| EPS Est. Change | N/A | +94.12% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $3.11 | ||
| Price Target | - | $20.00 |
| Price Tgt. Change | - | +543.09% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.85 | -$466.44 | -54,775.29% | |
| -$27.43 | N/A | +94.12% | |
| -$6.33 | N/A | +98.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -89.29% | ||
| -99.99% | ||
| -50.73% | ||
| -62.77% | ||
| 0.00% | ||
| 0.00% | ||
| -86.43% | ||
| +99.91% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $3.11 | ||
| $7.94 | ||
| SMA 200 vs Price | +155.14% | |
| $5.25 | ||
| SMA 50 vs Price | +68.85% | |
| 1.04 | ||
| $0.39 | ||
| 23.68 | ||
| 51.76% | ||
| 112.98% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$466.44 | ||
| -$3,300.00 | ||
| - | ||
| -$14.90M | ||
| - | ||
| -$14.86M | ||
| - | ||
| -$14.90M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.05 | ||
| 3.42 | ||
| 3.43 | ||
| - | ||
| - | ||
| -17.97 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.18 | ||
| 0.61 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $6.18M | ||
| $6.46M | ||
| $8.70M | ||
| $8.66M | ||
| $2.52M | ||
| $2.52M | ||
| $326.10K | ||
| $326.10K | ||
| $2.20M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $14.86M | ||
| $14.90M | ||
| $3,300.00 | ||
| $0.00 | ||
| $3,300.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$17.11M | ||
| -$4,200.00 | ||
| $23.03M | ||
| $4,200.00 | ||
| -$17.12M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Brookline Capital | ||
| Ladenburg Thalmann | ||
| Benchmark |
Analyst sentiment
Institutional ownership
Screeners with CNSP
FAQ
What is the ticker symbol for CNS Pharmaceuticals, Inc.?
The ticker symbol for CNS Pharmaceuticals, Inc. is NASDAQ:CNSP
Does CNS Pharmaceuticals, Inc. pay dividends?
No, CNS Pharmaceuticals, Inc. does not pay dividends
What sector is CNS Pharmaceuticals, Inc. in?
CNS Pharmaceuticals, Inc. is in the Healthcare sector
What industry is CNS Pharmaceuticals, Inc. in?
CNS Pharmaceuticals, Inc. is in the Biotechnology industry
What country is CNS Pharmaceuticals, Inc. based in?
CNS Pharmaceuticals, Inc. is headquartered in United States
When did CNS Pharmaceuticals, Inc. go public?
CNS Pharmaceuticals, Inc. initial public offering (IPO) was on November 8, 2019
Is CNS Pharmaceuticals, Inc. in the S&P 500?
No, CNS Pharmaceuticals, Inc. is not included in the S&P 500 index
Is CNS Pharmaceuticals, Inc. in the NASDAQ 100?
No, CNS Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is CNS Pharmaceuticals, Inc. in the Dow Jones?
No, CNS Pharmaceuticals, Inc. is not included in the Dow Jones index
When was CNS Pharmaceuticals, Inc. last earnings report?
CNS Pharmaceuticals, Inc.'s most recent earnings report was on November 14, 2025
When does CNS Pharmaceuticals, Inc. report earnings?
The date for CNS Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CNSP Official Website www.cnspharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1729427/000168316825008466/0001683168-25-008466-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1729427/000168316825002139/0001683168-25-002139-index.htm
- CNSP Profile on Yahoo Finance finance.yahoo.com/quote/CNSP
- CNSP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cnsp